'Killer disease' brief for F-H

Fleishman-Hillard is to handle comms for a controversial £500m medical research facility in central London that will harbour killer diseases such as cancer and bird flu.

The agency has been called in after residents expressed concern about the centre's proposed location near St Pancras Station, fearing that it could pose a health risk.

A Fleishman-Hillard spokesman said the agency would be running an 'engaging and compelling' campaign that would include public relations, crisis comms, government relations and stakeholder engagement, including talking to the local community and medical fraternity.

The UK Centre for Medical Research and Innovation (UKCMRI) is being launched as a joint project between the Medical Research Council, Cancer Research UK, The Wellcome Trust and University College London.

The UKCMRI is being funded by the sale of government land on the former British Library site where the unit will be based. It will house 1,500 scientists. Gordon Brown has hailed the UKCMRI as pivotal to British science, providing unique opportunities for translating basic discoveries into therapies.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in